Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Sep 10;17(9):1799–1806. doi: 10.1016/j.cgh.2018.09.008

Table 5:

Model information of the prediction model using dichotomized COL3A1and anti-CSF2 (the last row in Table 3).

Data Predictor Odds Ratio (95% CI) p-value
Group 3 vs. Group 1 (N=87) COL3A1 (≥1039) vs. COL3A1 (<1039) 19.17 (4.47, 137.04) 0.0004
anti-CSF2 (≥1.6) vs. anti-CSF2 (<1.6) 4.63 (1.73, 13.45) 0.0032

COL3A1 = collagen type III alpha 1 chain, Anti-CSF2 = autoantibodies against colony stimulating factor 2